Filtros de búsqueda

Lista de obras de Rafal Dziadziuszko

3105 Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial

A lack of correlation between mast cells, angiogenesis, and outcome in non-small cell lung cancer

artículo científico publicado en 2012

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

scientific article published on 20 June 2019

A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2005

A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer

artículo científico publicado en 2011

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

scientific article published on 15 March 2019

ALK alterations in salivary gland carcinomas

scientific article published on 25 November 2020

Activation of RAS family members confers resistance to ROS1 targeting drugs.

artículo científico publicado en 2015

Adoptive Cell Therapy-Harnessing Antigen-Specific T Cells to Target Solid Tumours

artículo científico publicado en 2020

Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.

scientific article published on March 2008

Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial

artículo científico publicado en 2019

Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study

artículo científico publicado en 2020

Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

scientific article published on 27 February 2019

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

artículo científico publicado en 2017

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

artículo científico publicado en 2018

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

artículo científico publicado en 2016

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

artículo científico publicado en 2016

Authors' Reply

Autopsy findings in small cell lung cancer

artículo científico publicado en 1996

Beneath the blood brain barrier: the challenge of diagnosis and management of central nervous system involvement in ALK-positive lung cancer

artículo científico publicado en 2013

Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy

artículo científico publicado en 2006

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

artículo científico publicado en 2011

Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer

artículo científico publicado en 2006

CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab.

artículo científico publicado en 2015

Can an Integrative SNP Approach Substitute Standard Identification in Comprehensive Case/Control Analyses?

artículo científico publicado en 2018

Cardiovascular complications after radiotherapy

artículo científico publicado en 2018

Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors.

artículo científico publicado en 2018

Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer

artículo científico publicado en 2006

Clinical implications of molecular abnormalities in lung cancer

artículo científico publicado en 1998

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

artículo científico publicado en 2007

Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.

artículo científico publicado en 2010

Conservative treatment for carcinoma of the anus--a report of 35 patients

artículo científico publicado el 1 de enero de 2003

Continuous 7-Days-A-Week External Beam Irradiation in Locally Advanced Cervical Cancer: Final Results of the Phase I/II Study ⬇️

artículo científico publicado el 11 de mayo de 2011

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain.

artículo científico publicado en 2012

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer

artículo científico publicado en 2012

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

artículo científico publicado en 2015

Decortication in chronic pleural empyema - effect on lung function

artículo científico publicado en 2002

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report

artículo científico publicado en 2019

Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?

scientific article published on 01 October 2019

EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?

artículo científico publicado en 2013

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

scientific article published on 01 June 2020

Early results of a trimodality treatment for superior sulcus tumors

artículo científico publicado en 2014

Effectiveness of osimertinib in patients with lung adenocarcinoma in clinical practice - the Expanded Drug Access Program in Poland

scientific article published on 01 January 2020

Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study

scientific article published on 07 March 2019

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials

scientific article published on 11 December 2019

Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2

scientific article published on 01 April 2019

Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.

artículo científico publicado en 2015

Epidermal growth factor receptor (EGFR) inhibitors and derived treatments ⬇️

artículo científico publicado el 1 de septiembre de 2012

Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy

artículo científico publicado en 2006

Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.

artículo científico publicado en 2008

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer

artículo científico publicado en 2006

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2009

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

artículo científico publicado en 2017

Exacerbation of diabetes related to exemestane treatment

artículo científico publicado en 2008

Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)--a preliminary report

artículo científico

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

artículo científico publicado en 2014

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer

artículo científico publicado en 2015

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

scientific article published on 13 July 2011

First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay

artículo científico publicado en 2008

Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer

artículo científico publicado en 2008

Folate/homocysteine metabolism and lung cancer risk among smokers

Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Galectin-9 in non-small cell lung cancer

artículo científico publicado en 2019

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

artículo científico publicado en 2002

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy

scientific article published on 01 April 2019

Identification of serum proteome components associated with progression of non-small cell lung cancer

artículo científico publicado en 2014

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

artículo científico publicado en 2010

Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studies

artículo científico publicado en 2019

Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism

artículo científico publicado en 2006

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

artículo científico

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

artículo científico publicado en 2010

Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.

artículo científico publicado en 1993

Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients

scientific article published on 01 July 2006

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.

artículo científico publicado en 2017

Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer

artículo científico publicado en 2004

Lung Cancer in Poland

artículo científico publicado en 2020

Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.

artículo científico publicado en 2018

Lung function in patients operated for chronic pleural empyema

artículo científico publicado en 2005

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective

artículo científico publicado en 2015

MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).

artículo científico publicado en 2004

MHC class II expression in lung cancer.

artículo científico publicado en 2017

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes

artículo científico publicado en 2013

Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors

scientific article published on 21 October 2018

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study

artículo científico publicado en 2007

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

artículo científico publicado en 2014

MicroRNA in lung cancer diagnostics and treatment.

artículo científico publicado en 2011

Miliary brain metastases in a patient with ROS1-rearranged lung adenocarcinoma: a case report

artículo científico publicado en 2014

Molecular diagnostics of lung cancer

artículo científico publicado en 2015

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

artículo científico publicado en 2006

NSCLC molecular testing in Central and Eastern European countries.

artículo científico publicado en 2018

Nazartinib in EGFR Thr790Met-mutant non-small-cell lung cancer

artículo científico publicado en 2020

Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.

artículo científico publicado en 2016

Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer

artículo científico publicado en 2011

OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice

scholarly article by K. Haslett et al published April 2016 in Radiotherapy and Oncology

OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers

scientific article published on 01 August 2019

Of mice and men: olfactory neuroblastoma among animals and humans

artículo científico

Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practice

artículo científico publicado en 2020

Osimertinib - effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors.

artículo científico publicado en 2017

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

artículo científico publicado en 2004

P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.

artículo científico publicado en 2004

P53 and P16 gene mutations in non-small cell lung cancer

artículo científico publicado en 2002

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes.

scientific article published on 09 March 2017

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

artículo científico publicado en 2016

Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study.

artículo científico publicado en 2017

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

artículo científico publicado en 2020

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

scientific article published on 06 April 2020

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

artículo científico publicado en 2017

Primary malignant fibrous histiocytoma of the lung

artículo científico publicado en 2007

Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer

scientific article published on 01 May 2006

Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts

scientific article published on 31 January 2019

Pulsed dose rate brachytherapy of lip cancer

artículo científico publicado en 2013

Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer.

scientific article published on 09 December 2016

Quantitative immunohistochemistry in lung cancer: clinical perspective

artículo científico publicado en 2010

Radiation dose to the left anterior descending coronary artery during interstitial pulsed-dose-rate brachytherapy used as a boost in breast cancer patients undergoing organ-sparing treatment.

artículo científico publicado en 2017

Randomized Clinical Trials Using New Technologies in Radiation Oncology: Ethical Dilemma for Medicine and Science ⬇️

artículo científico publicado el 1 de enero de 2012

Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients

artículo científico publicado en 2020

Report on the 4th Central European Lung Cancer Conference, September 26-29, 1996, Gdańsk, Poland

artículo científico publicado el 1 de enero de 1997

Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study

artículo científico publicado en 2014

Resistance mechanisms to targeted therapies in ROS1+ and ALK+ non-small cell lung cancer.

artículo científico publicado en 2018

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

artículo científico publicado en 2006

Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification

artículo científico publicado en 2000

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.

artículo científico publicado en 2009

Rociletinib in EGFR-mutated non-small-cell lung cancer

artículo científico publicado en 2015

Role of quantitative chest perfusion computed tomography in detecting diabetic pulmonary microangiopathy ⬇️

artículo científico publicado el 3 de diciembre de 2010

Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine

artículo científico publicado en 2020

STELLAR: Final updated results of a phase II trial of TTFields with chemotherapy for unresectable malignant pleural mesothelioma

scientific article published on 01 April 2019

Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?

artículo científico publicado en 2006

Serum anti-P53 antibodies (AB-anti-P53) in patients with advanced non-small cell lung cancer (NSCLC)

artículo científico publicado el 1 de enero de 2002

Serum lipid profile discriminates patients with early lung cancer from healthy controls

artículo científico publicado en 2017

Serum mass profile signature as a biomarker of early lung cancer.

artículo científico publicado en 2016

Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance

scientific article published on 01 January 2001

Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice

artículo científico publicado en 2018

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

artículo científico publicado en 2002

Stereotactic body radiotherapy for central lung tumours: Author reply.

artículo científico publicado en 2015

T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer

artículo científico publicado en 2019

TEMPORARY REMOVAL: Updated overall survival and final progression-free survival data for patients with treatment-naïve advanced ALK-positive non-small-cell lung cancer in the ALEX study

artículo científico publicado en 2020

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

artículo científico publicado en 2003

Ten years of experience in lung cancer screening in Gdańsk, Poland: a comparative study of the evaluation and surgical treatment of 14 200 participants of 2 lung cancer screening programmes†

scientific article published on 18 March 2019

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.

artículo científico publicado en 2017

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

artículo científico publicado en 2014

The influence of blood transfusion on survival in operated non-small cell lung cancer patients

artículo científico publicado en 2003

The insulin-like growth factor pathway in lung cancer

artículo científico publicado en 2008

The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers

scientific article published on July 2009

The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts

artículo científico publicado en 2019

Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer

artículo científico publicado en 2012

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

artículo científico publicado en 2020

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial

artículo científico publicado en 2019

Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure

scientific article published on 01 March 2007

Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report

artículo científico publicado en 2007

Update on epidermal growth factor receptor inhibitor development in lung cancer.

artículo científico publicado en 2006

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study

artículo científico publicado en 2019

Whole Brain Radiotherapy for Patients with Non-Small Cell Lung Cancer with EGFR Mutations-Why and When?

artículo científico publicado en 2016

[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]

scientific article published on 01 January 2005

[Results of treatment for chronic pleural empyema]

scientific article published on 01 January 2003

[Systemic treatment of non-small cell lung cancer--recommendations based on the results of reliable clinical trials]

scientific article published on 01 January 2008

[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients].

artículo científico publicado en 2002

[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].

artículo científico publicado en 2014

[Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma]

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda